Clinical Trials on Myeloproliferative Neoplasm in New Zealand
Total 16890 results
-
Novartis PharmaceuticalsTerminatedPrimary Myelofibrosis | Post-Polycythemia Vera | Post-Essential ThrombocytopeniaUnited States
-
University Health Network, TorontoActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Neoadjuvant Treatment | Debulking Surgical ProceduresCanada, United Kingdom, Spain, New Zealand
-
Hoffmann-La RocheCompletedBreast Cancer, Colorectal CancerNew Zealand, Australia, United Kingdom
-
Incyte CorporationNovartis PharmaceuticalsCompletedPolycythemia VeraUnited States, Canada, France, Italy, United Kingdom, China, Belgium, Germany, Spain, Turkey, Japan, Australia, Korea, Republic of, Netherlands, Russian Federation, Argentina, Thailand, Hungary
-
Sumitomo Pharma America, Inc.RecruitingMyelofibrosisUnited States, Belgium, France, Japan, Australia, Italy, United Kingdom
-
Keros Therapeutics, Inc.IQVIA BiotechRecruitingMyelofibrosisAustralia
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompletedLentigo MalignaAustralia, Brazil, New Zealand
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationCompletedMyelomonocytic LeukemiaUnited States
-
University of RochesterCompleted
-
NovartisCompletedLeukemiaUnited States
-
ExelixisTerminatedMyeloproliferative Disorders | Polycythemia Vera | Thrombocythemia, Essential | MyelofibrosisUnited States
-
Heinrich-Heine University, DuesseldorfCelgene CorporationCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, ChronicGermany
-
Geron CorporationRecruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | NeutropeniaUnited States
-
Olivia Newton-John Cancer Research InstituteBristol-Myers SquibbActive, not recruitingNeuroendocrine Tumors | Advanced Biliary Tract Cancer | Female Reproductive System Neoplasm | MSI-H Solid Malignant TumorNew Zealand, Australia
-
Memorial Sloan Kettering Cancer CenterNovartisCompletedLeukemia | Gastric Cancer | Chronic Myelogenous LeukemiaUnited States
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedNon Small Cell Lung CancerAustralia, New Zealand, Spain
-
Bristol-Myers SquibbTerminatedTumorItaly, United States, New Zealand
-
Proacta, IncorporatedTerminatedUnspecified Adult Solid Tumor, Protocol SpecificNew Zealand, United States
-
John MascarenhasNational Cancer Institute (NCI); Formation Biologics; Myeloproliferative Neoplasm...CompletedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis | Post ET MF | Post PV MFUnited States
-
Astex Pharmaceuticals, Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelocytic Leukemia | Myelodysplastic Syndrome/NeoplasmUnited States, Canada
-
Dana-Farber Cancer InstituteThe Leukemia and Lymphoma SocietyRecruitingMyelodysplastic-Myeloproliferative Diseases | Waldenstrom Macroglobulinemia | Smoldering Multiple Myeloma | Chronic Lymphocytic Leukemia (CLL) | Hematological Malignancies | Monoclonal Gammopathy of Undetermined Significance (MGUS) | B-cell Malignancy, Low-grade | Myelodysplastic Syndrome With Low-grade... and other conditionsUnited States
-
Bristol-Myers SquibbWithdrawnMyeloid Leukemia, Chronic, Chronic-PhaseUnited States
-
University of ZurichUniversity Hospital, Strasbourg, France; University College London Hospitals; University Hospital, Essen and other collaboratorsCompletedNeoplasmsUnited Kingdom, Germany, Switzerland, United States, France, New Zealand
-
Memorial Sloan Kettering Cancer CenterEisai Inc.Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedChronic Myeloid LeukemiaUnited States, Belgium, France, Korea, Republic of
-
PfizerTerminatedNeuroblastomaAustralia, Korea, Republic of, United States, Portugal, New Zealand, Sweden
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia in Chronic PhaseUnited States
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of AlexionCompletedParoxysmal Nocturnal Hemoglobinuria (PNH)United Kingdom, New Zealand, Korea, Republic of, Italy
-
Daiichi SankyoAvailableEpidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung CancerUnited States
-
Australasian Gastro-Intestinal Trials GroupNational Health and Medical Research Council, Australia; European Organisation... and other collaboratorsActive, not recruitingGastric CancerAustralia, New Zealand
-
Australian & New Zealand Children's Haematology...National Health and Medical Research Council, Australia; Secura Bio, Inc.TerminatedRhabdoid Tumor | Atypical Teratoid/Rhabdoid Tumor | Malignant Rhabdoid Tumor | Recurrent Brain Tumor, ChildhoodAustralia, New Zealand, United States
-
Kura Oncology, Inc.CompletedLeukemia, Myelomonocytic, ChronicUnited States
-
AstraZenecaUniversity of Texas; Gustave Roussy, Cancer Campus, Grand Paris; New York City...CompletedPrimary Myelofibrosis (PMF) | Post-Polycythaemia Vera | Essential Thrombocythaemia MyelofibrosisUnited States, France
-
Astex Pharmaceuticals, Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
Astex Pharmaceuticals, Inc.Eisai Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
Northwell HealthNew York Blood CenterCompletedHodgkin Lymphoma | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLeukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia | Non-Hodgkins Lymphoma | Hodgkins LymphomaUnited States
-
Hackensack Meridian HealthTerminatedMyeloproliferative Disorders | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myeloid MalignanciesUnited States
-
Samus Therapeutics, Inc.TerminatedPrimary Myelofibrosis | Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States
-
Ariad PharmaceuticalsTerminatedChronic Myeloid LeukemiaUnited States, Australia, Austria, Belgium, Canada, Czech Republic, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Singapore, Slovakia, Spain, Sweden, Switz... and more
-
Ariad PharmaceuticalsUnited BioSource, LLCTerminatedMyeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALLUnited States
-
National Cancer Institute (NCI)TerminatedLymphoma | Leukemia | Myeloproliferative Disorders | Myelodysplastic Syndrome | Multiple MyleomaUnited States
-
CelgeneCompletedMyelofibrosis | Myeloid Metaplasia | Myelofibrosis With Myeloid MetaplasiaUnited States, Italy, United Kingdom, Austria, Spain
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Breast Cancer | Chronic Myeloproliferative Disorders | Anemia | Small Intestine Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada
-
CTI BioPharmaTerminatedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Australia, Belgium, Czechia, France, Germany, Hungary, Italy, Netherlands, New Zealand, Russian Federation, United Kingdom
-
Trans Tasman Radiation Oncology GroupThe Royal Australian and New Zealand College of RadiologistsCompletedGastric CancerAustralia, New Zealand
-
Ronald HoffmanNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumTerminated
-
Queensland Centre for Gynaecological CancerThe University of Queensland; Queensland University of TechnologyActive, not recruitingComplex Endometrial Hyperplasia With Atypia | Grade 1 Endometrial Endometrioid AdenocarcinomaAustralia, New Zealand
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia